April 24 (UPI) --The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract infections, the U.S. Food and Drug Administration announced ...

Periurethral and intravaginal creams both aided prevention of recurrent urinary tract infe ...

European-funded consortium brings together researchers from 13 countries to evaluate bacteriophage therapy as a potential ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant GSK ...

Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting millions of people each year. While they are often associated with women due to anatomical factors, ...

Dealing with chronic urinary tract infections (UTIs) means facing more than the occasional discomfort. It's like being on a never ending battlefield against an unseen adversary, making simple daily ...

What often begins as a mild burning sensation during urination or an increased urge to visit the toilet can quickly become a serious medical emergency if left untreated.Health experts warn that ...

“Recurrent UTIs can significantly affect quality of life,” says Gina M. Badalato, MD, a urologist and associate professor of urology at NewYork-Presbyterian/Columbia University Irving Medical Center ...

Urinary tract infections (UTIs) are common, but recent studies have shown that the relationship between diet and UTIs is more complex than previously thought. Dietary choices, along with food safety ...

Add Yahoo as a preferred source to see more of our stories on Google. A new oral medication to treat urinary tract infections in women, Pivya, is approved for use following three clinical trials ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...